dc.contributor.author |
Singer, Elisabeth |
|
dc.contributor.author |
Walter, Carolin |
|
dc.contributor.author |
Rischert, Nadine |
|
dc.contributor.author |
Rieß, Olaf |
|
dc.date.accessioned |
2020-11-03T08:47:51Z |
|
dc.date.available |
2020-11-03T08:47:51Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1873-7064 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/109095 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Pergamon - Elsevier Science Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.neuropharm.2019.107812 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200715072417_02293 |
|
utue.personen.roh |
Singer, Elisabeth |
|
utue.personen.roh |
Walter, Carolin |
|
utue.personen.roh |
Fabbro, Doriano |
|
utue.personen.roh |
Rageot, Denise |
|
utue.personen.roh |
Beaufils, Florent |
|
utue.personen.roh |
Wymann, Matthias P. |
|
utue.personen.roh |
Rischert, Nadine |
|
utue.personen.roh |
Riess, Olaf |
|
utue.personen.roh |
Hillmann, Petra |
|
utue.personen.roh |
Huu Phuc Nguyen |
|
dcterms.isPartOf.ZSTitelID |
Neuropharmacology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 107812 |
de_DE |
dcterms.isPartOf.ZS-Volume |
162 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |